Perspectives in Cardiology - 2001 Back Issues

2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001

November / December 2001

Cardiac Transplantation:
The Role of the Primary-Care Physician
The care of a patient following cardiac transplantation requires a team approach, involving the transplant center and the family physician. This requires the primary- care physician to have adequate knowledge of the basics of transplantation.

By Lynn P. Straatman, MD, FRCPC

Cardiac Angiogenesis: Part 2
An Emerging Technology for the Treatment of CAD
Part 2 of this article looks at issues of study design, efficacy end points and potential complications of treatment with angiogenic agents. The authors also look at future research, which may provide feasible therapy in the future.

By Michael J.B. Kutryk, MD, PhD; and Duncan J. Stewart, MD

October 2001

Lipid-Lowering Therapy For Acute Coronary Syndromes
There is a large amount of evidence that supports the early use of statins in the treatment of acute coronary syndromes. The anti-inflammatory, anti-thrombotic and anti-oxidant properties of this class of medications all promise great potential in reducing the short- and long-term sequelae of acute coronary events by the pacification of coronary plaques and improvement of vasomotor function.

By Graham C. Wong, MD; and Christian Constance, MD

Cardiac Angiogenesis: Part I
An Emerging Technology for the Treatment of CAD
Part I of this article defines angiogenesis, vasculogenesis and arteriogenesis and looks at pre-clinical studies which support the fact that vascular growth factors can promote angiogenesis to improve blood flow to ischemic muscle.

By Michael J.B. Kutryk, MD, PhD; and Duncan J. Stewart, MD

September 2001

Screening for Sudden Cardiac Death in Adolescent Athletes
By John A.M. Morphet, MD, FRCPC, FACC, FESC
Although sudden cardiac death among adolescent athletes is a rare occurrence, it may be prevented through careful screening. Taking the time to perform a careful history, functional inquiry, physical examination, and an electrocardiogram may save a life.

White Coat Hypertension
By Dr. Nadia Khan, MD, FRCPC; and Norman RC Campbell, MD, FRCPC
Patients are often misdiagnosed as having hypertension when they actually have white coat hypertension (WCH). For those suspected of having WCH, ambulatory or home blood pressure monitoring should be considered. This article discusses the predictors, prognosis and management of WC effect and hypertension.


2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001
	November / December 2001 Cardiac Transplantation: The Role of the Primary-Care Physician The care of a patient following cardiac transplantation requires a team approach, involving the transplant center and the family physician. This requires the primary- care physician to have adequate knowledge of the basics of transplantation. By Lynn P. Straatman, MD, FRCPC Cardiac Angiogenesis: Part 2 An Emerging Technology for the Treatment of CAD Part 2 of this article looks at issues of study design, efficacy end points and potential complications of treatment with angiogenic agents. The authors also look at future research, which may provide feasible therapy in the future. By Michael J.B. Kutryk, MD, PhD; and Duncan J. Stewart, MD

	October 2001 Lipid-Lowering Therapy For Acute Coronary Syndromes There is a large amount of evidence that supports the early use of statins in the treatment of acute coronary syndromes. The anti-inflammatory, anti-thrombotic and anti-oxidant properties of this class of medications all promise great potential in reducing the short- and long-term sequelae of acute coronary events by the pacification of coronary plaques and improvement of vasomotor function. By Graham C. Wong, MD; and Christian Constance, MD Cardiac Angiogenesis: Part I An Emerging Technology for the Treatment of CAD Part I of this article defines angiogenesis, vasculogenesis and arteriogenesis and looks at pre-clinical studies which support the fact that vascular growth factors can promote angiogenesis to improve blood flow to ischemic muscle. By Michael J.B. Kutryk, MD, PhD; and Duncan J. Stewart, MD

	September 2001 Screening for Sudden Cardiac Death in Adolescent Athletes By John A.M. Morphet, MD, FRCPC, FACC, FESC Although sudden cardiac death among adolescent athletes is a rare occurrence, it may be prevented through careful screening. Taking the time to perform a careful history, functional inquiry, physical examination, and an electrocardiogram may save a life. White Coat Hypertension By Dr. Nadia Khan, MD, FRCPC; and Norman RC Campbell, MD, FRCPC Patients are often misdiagnosed as having hypertension when they actually have white coat hypertension (WCH). For those suspected of having WCH, ambulatory or home blood pressure monitoring should be considered. This article discusses the predictors, prognosis and management of WC effect and hypertension.

	August 2001 Primary Prevention of Cardiovascular Diseases By J. George Fodor, MD, PhD, FRCPC The cost of cardiovascular disease (CVD) in Canada is approximately $20 billion annually. With the aging population, we can expect an increase in the prevalence of CVD. This article looks at the emergence of risk factors and examines primordial, primary and secondary prevention. Special Report: American Society of Hypertension Sixteenth Annual Scientific Meeting and Exposition Editorial Staff From May 15 to 19, 2001, approximately 4,000 physicians and researchers from around the world met in San Francisco to develop, advance and exchange information on hypertension and related cardiovascular diseases. In this issue of Perspectives in Cardiology, we bring you a summary of two presentations we thought to be of special interest to the primary-care physician. We hope you find these summaries to be both interesting and informative. Hypertension in the Octogenarian; and Hypertension in Pregnancy

	June/July 2001 ST-Segment Elevation AMI: The First 12 Hours By Michel Le May, MD, FRCPC, FACC Acute myocardial infarction (AMI) accounts for half of the deaths due to ischemic heart disease and is associated with significant use of resources. Because time from symptom onset is critical, efforts must be made to recognize AMI and prevent complications. Special Report: The ACC 50th Annual Scientific Session — Part Two Editorial Staff From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology 50th Annual Scientific Session. In this issue of Perspectives in Cardiology, we bring you the second of two installments containing summaries we believe will be both interesting and useful for the Canadian family doctor. In this issue we feature: Self Efficacy and Cardiac Rehabilitation; and Predictors of Quality of Life After Myocardial Infarction.

	May 2001 Heart Failure:Getting to the Heart of the Problem By Anique Ducharme, MD, MSc, FRCP(C) With a prevalence of 1% to 2% among the general population, heart failure has become a major problem, both in the clinical setting and in the public-health sector. Approximately 300,000 Canadians suffer from congestive heart failure, and the number is escalating. Special Report: The ACC 50th Annual Scientific Session — Part One Editorial Staff From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology 50th Annual Scientific Session. Over the next two issues of Perspectives in Cardiology, we bring you summaries of four presentations we believe will be both interesting and useful for the Canadian family doctor. In this issue we feature: The Diagnosis of Diastolic Heart Failure; and Medication Doses Following PTCA.

	April 2001 The Sleeping Heart: Hibernating Myocardium By Gurpreet Parmar and Akbar V. Lalani, MSc, MBBS, FRCP(C), FACC There has been a noticeable change in our approach to patients with end-stage heart failure. This is reflected in the number of patients previously considered to be candidates for intense anti-failure therapy...who are now undergoing revascularization procedures. Exercise Training in Chronic Heart Failure: A Sea Change By Dr. Terence Kavanagh, MD, FRCPC Over the past 15 years there has been increasing evidence that encouraging rest and restricting physical activity can be counterproductive, and that a medically prescribed exercise training regimen helps to alleviate symptoms, improve exercise tolerance, and enhance quality of life.